Mr. Harry Simeonidis

President and Director
Harry Simeonidis has more than 25 years’ experience in global executive management roles in healthcare, pharmaceutical and life sciences businesses. His previous roles include CEO of Australia and New Zealand at GE Healthcare and, more recently, General Manager for Surgery Asia Pacific at GE Healthcare.

Mr Simeonidis also serves as Executive Director and General Manager of FarmaForce.

Dr. Jean Claude Becker

Chief Operating Officer, Executive Vice President and Director
Dr Becker is a widely published, global researcher with expertise in developing and positioning innovative products.

His experience includes Group Director of Global Clinical Research in Immunology at Bristol-Myers Squibb, a position he held for 12 years, and senior roles at Sandoz and Pfizer.

Mr. Spiro Sakiris

B.Bus, Dip Law, CA
Chief Financial Officer
Mr. Sakiris has 32 years’ experience in advising businesses in accounting and taxation, business advisory, IPOs and capital raising, business risks identification and management, and business system designs across many industries, including the application of IFRS and U.S. GAAP for the life science industry.

Mr. Sakiris is a member of the Institute of Chartered Accounts of Australia & New Zealand, a registered Series 28 principal with iQ Capital (USA) LLC and is registered with FINRA. He also serves as Special Projects Lead at The iQ Group Global.

Mr. Jonathan Hurd

Chairman of the Board
Jonathan Hurd is the current CEO and founder of Asgard Regulatory Group, an organization that provides broker-dealer and investment adviser compliance consulting services in the U.S. and internationally.

Previously Mr Hurd was the Chief Compliance Officer for several financial institutions and has served on the Board of Directors for numerous investment companies. Mr Hurd was a Supervisor of Examiners at FINRA and has conducted large-scale enforcement cases jointly with the Justice Department and the FBI.

Mr. Leon Kempler

Mr Kempler is a highly experienced business leader of the APAC region. Formally recognized in his field, Mr Kempler received the Medal of Order from the Governor General in both 1998 and 2018, recognizing his services to Australia’s international business relations and contribution to Australia’s development in culture, education, and medicine.

With more than 30 years’ experience, Mr Kempler’s honorary roles have included Chairman of the Advisory Council of the National Science and Technology Centre – Questacon; and National Chairman of the Australia-Israel Chamber of Commerce, among many others.

Dr. Yong-Jiang Hei

M.D., Ph.D (Pharmacology)
Dr Yong-Jiang Hei currently serves as the Chief Medical Officer at Zai Lab in Shanghai. Previously, Dr Hei was the Corporate VP and Chief Medical Officer at Qilu Pharmaceuticals, China and was the former Executive Medical Director of AMGEN China. He has extensive expertise and hands-on experience in clinical strategy, clinical trial design, and conduct and regulatory filings. He currently serves as Chief Medical Officer at biopharmaceutical company Ambrx.

Ms. Victoria Gavrilenko

Operations Manager and Director
Ms Gavrilenko is responsible for the coordination of activities within the U.S. as well as overseas business partners and contractors.

Dr. George Margelis

Dr. Margelis is a medical practitioner who has been deeply involved in technology for the last 30 years.

Dr Margelis’s previous roles include Chief Information Officer of Macquarie Health Corporation where he led an innovative software development team producing online health applications. He has also worked at Intel, the Intel-GE Innovation spin off, and as a senior adviser to HIMSS, the international peak body for health technology.

He is currently Adjunct Associate Professor at the University of Western Sydney with the TeleHealth Research & Innovation Laboratory (THRIL) and a member of Ignition Labs, a healthcare start-up incubator.

Dr. Tom Parmakellis

Dr. Tom Parmakellis has 25 years’ experience as a medical practitioner. Having negotiated exclusive distribution rights for internationally recognized medical lasers in Australia, Dr Parmakellis’s experience in healthcare markets reaches back to 1996 when he introduced Laser Hair removal into the Australian market.

In 2009, Dr Parmakellis founded Lookfresh Cosmestic Medicine, which he still owns today, and in 2017 he founded SkinLift Ultherapy.

Dr. Parmakellis holds a MBBS from the University of Sydney, is a fellow of the Royal Australian College of General Practitioners (FRACGP) and a fellow of the Cosmetic Physicians College Australasia (FCPCA).

Scientific Board

Dr. George Syrmalis

Executive Chairman and CEO of The iQ Group Global
Dr. Syrmalis is trained in Nuclear Medicine-radiation immunology and established iQnovate, member of The iQ Group Global, in 2011. Previously, Dr. Syrmalis founded and led as CEO and Chairman The Bionuclear Group SA, (1995-2005) incorporating Antisoma SA, Bionuclear Institute of Diagnosis and Therapy SA, Bionuclear Research and Development SA and Vitalcheck SA. He developed a business model by addressing unmet clinical needs and leveraging on synergies between Bionuclear Group companies.

• Antisoma SA: focused on development of novel biologic compounds both radio diagnostic and radio therapeutic in the area of oncology.

• Bionuclear Institute for Diagnosis and Therapy SA: expanded into medical centers-renal dialysis clinics and the development of Europe’s most prominent reference pathology service.

• Bionuclear Research and Development SA: novel and generic radiopharmaceutical production.

• Vitalcheck SA: Research, development and commercialization of point of care tests for professional and layman use. From 2005 onwards George continued his career as advisor to the Biopharmaceutical industry, advising on translational clinical trials, biomarkers and strategy to commercialize novel biologic entities in the areas of oncology, epilepsy and autoimmune diseases.

Professor Paul Dastoor

Ph.D, B.A. (Hons)
Director, Centre for Organic Electronics, University of Newcastle
Paul Dastoor is a Professor in Physics in the School of Mathematical and Physical Sciences and the Director of the Centre for Organic Electronics at the University of Newcastle in Australia. He received his B.A. degree in Natural Sciences from the University of Cambridge in 1990 and his PhD in Surface Physics, also from the University of Cambridge, in 1995.

His expertise covers surface analysis, electron spectroscopy, thin film growth, organic electronics, organosilane chemistry, polymer films, atom beam optics and microscopy and medical devices. His research can be grouped in 3 main areas: (1) Helium Atom Microscopy, (2) Polymer Adsorption on Metal Surfaces and (3) Organic Electronic Devices. Helium Atom Microscopy Atomic scattering from surfaces has matured into a unique analytical technique for the study of formation of thin film structures.

Sign Up

Register for email alerts for the latest developments on the Saliva Glucose Biosensor and GBS Inc.

  • This field is for validation purposes and should be left unchanged.